ARTICLE | Clinical News
Jetrea ocriplasmin regulatory update
March 24, 2014 7:00 AM UTC
ThromboGenics said Swissmedic approved Jetrea ocriplasmin to treat vitreomacular traction (VMT), including when associated with a macular hole <=400 microns in diameter. The Alcon Inc. ophthalmic uni...